Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Sarepta Therapeutics, Inc. (SRPT)

Johnson Fistel, PLLP said it is investigating potential fiduciary duty breaches by certain officers and directors of Sarepta Therapeutics (SRPT) for current long-term shareholders. The notice does not quantify damages or timing, but the inquiry raises governance/legal overhang risk for the stock.

Analysis

Johnson Fistel, PLLP said it is investigating potential fiduciary duty breaches by certain officers and directors of Sarepta Therapeutics (SRPT) for current long-term shareholders. The notice does not quantify damages or timing, but the inquiry raises governance/legal overhang risk for the stock.